Literature DB >> 1846538

Endothelin-3 stimulates production of endothelium-derived nitric oxide via phosphoinositide breakdown.

T Emori1, Y Hirata, K Kanno, K Ohta, S Eguchi, T Imai, M Shichiri, F Marumo.   

Abstract

Cultured bovine endothelial cells (EC) have specific receptors for endothelin (ET)-3 functionally coupled to phosphoinositide breakdown. We studied whether ET-3 stimulates synthesis of nitric oxide (NO), an endothelium-derived relaxing factor that activates soluble guanylate cyclase in EC, and whether the ET-3-induced NO formation involves G-proteins. ET-3 dose-dependently stimulated production of intracellular cGMP in EC, of which effects were abolished by pretreatment with NG-monomethyl L-arginine, an inhibitor of NO synthesis, and methylene blue, an inhibitor of soluble guanylate cyclase. The stimulatory effects of ET-3 on cGMP production, inositol trisphosphate formation and increase in cytosolic free Ca2+ concentration were similarly blocked by pretreatment with pertussis toxin (PTX). These data suggest that ET-3 induces synthesis of NO mediated by phosphoinositide breakdown via PTX-sensitive G-protein in EC.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1846538     DOI: 10.1016/0006-291x(91)90510-e

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  Endothelin receptor subtype B mediates synthesis of nitric oxide by cultured bovine endothelial cells.

Authors:  Y Hirata; T Emori; S Eguchi; K Kanno; T Imai; K Ohta; F Marumo
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

2.  Sensitivity of G-protein involved in endothelin-1-induced Ca2+ influx to pertussis toxin in porcine endothelial cells in situ.

Authors:  H Aoki; S Kobayashi; J Nishimura; H Kanaide
Journal:  Br J Pharmacol       Date:  1994-04       Impact factor: 8.739

3.  The effect of endothelins on nitric oxide and prostacyclin production from human umbilical vein, porcine aorta and bovine carotid artery endothelial cells in culture.

Authors:  D G White; J W Mundin; M J Sumner; I S Watts
Journal:  Br J Pharmacol       Date:  1993-08       Impact factor: 8.739

4.  Incomplete inhibition of the pressor effects of endothelin-1 and related peptides in the anaesthetized rat with BQ-123 provides evidence for more than one vasoconstrictor receptor.

Authors:  L McMurdo; R Corder; C Thiemermann; J R Vane
Journal:  Br J Pharmacol       Date:  1993-02       Impact factor: 8.739

5.  Different localization of two types of endothelin receptor mRNA in microdissected rat nephron segments using reverse transcription and polymerase chain reaction assay.

Authors:  Y Terada; K Tomita; H Nonoguchi; F Marumo
Journal:  J Clin Invest       Date:  1992-07       Impact factor: 14.808

6.  Endothelin-3-induced relaxation of rat thoracic aorta: a role for nitric oxide formation.

Authors:  H Moritoki; H Miyano; S Takeuchi; M Yamaguchi; T Hisayama; W Kondoh
Journal:  Br J Pharmacol       Date:  1993-04       Impact factor: 8.739

7.  P2U receptor is linked to cytosolic Ca2+ transient and release of vasorelaxing factor in bovine endothelial cells in situ.

Authors:  Y Miyagi; S Kobayashi; J Nishimura; M Fukui; H Kanaide
Journal:  J Physiol       Date:  1996-05-01       Impact factor: 5.182

8.  Elevated plasma levels of endothelin are associated with the severity of sepsis and presence of shock in contrast to the levels of atrial natriuretic peptide.

Authors:  A Beishuizen; J M Götz; L Kip; C Haanen; I Vermes
Journal:  Mediators Inflamm       Date:  1992       Impact factor: 4.711

9.  SCF-KIT signaling induces endothelin-3 synthesis and secretion: Thereby activates and regulates endothelin-B-receptor for generating temporally- and spatially-precise nitric oxide to modulate SCF- and or KIT-expressing cell functions.

Authors:  Lei L Chen; Jing Zhu; Jonathan Schumacher; Chongjuan Wei; Latha Ramdas; Victor G Prieto; Arnie Jimenez; Marco A Velasco; Sheryl R Tripp; Robert H I Andtbacka; Launce Gouw; George M Rodgers; Liansheng Zhang; Benjamin K Chan; Pamela B Cassidy; Robert S Benjamin; Sancy A Leachman; Marsha L Frazier
Journal:  PLoS One       Date:  2017-09-07       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.